Interleukin-10 (IL-10) in Experimental Visceral Leishmaniasis and IL-10 Receptor Blockade as Immunotherapy

Interleukin-10 (IL-10) is thought to promote intracellular infection, including human visceral leishmaniasis, by disabling Th1 cell-type responses and/or deactivating parasitized tissue macrophages. To develop a rationale for IL-10 inhibition as treatment in visceral infection, Th1 cytokine-driven r...

全面介紹

書目詳細資料

發表在:	Infect Immun
Principais autores:	Murray, Henry W., Lu, Christina M., Mauze, Smita, Freeman, Sherry, Moreira, Andre L., Kaplan, Gilla, Coffman, Robert L.
格式:	Artigo
語言:	Inglês
出版:	American Society for Microbiology (ASM) 2002
主題:	Fungal and Parasitic Infections
在線閱讀:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC130311/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12379707/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/IAI.70.11.6284-6293.2002
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!